Contribution: Industrial Research Assistance Program – Contributions to Firms
Swift Innovations Inc.
$154,000.00
Advanced Cosmeceutical Products Using a Nano Material Delivery System for Bioactives
FY 2024-25 · 2024-06-01
Summary
Swift Innovations intends to develop an improved delivery system for controlled release of bioactives on epidermal surfaces using customized substrate material.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Edmonton|Edmonton, Alberta, Canada
Recipient Type
For-profit organization
Business Number
761130715
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2024-06-01 | 2024-25 | $154,000.00 |
| 1 | 2024-06-01 | 2024-25 | $154,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 61 jours.
Agreement End Date
2025-10-31
Agreement Number
1020201
Agreement Start Date
2024-06-01
Agreement Title
Advanced Cosmeceutical Products Using a Nano Material Delivery System for Bioactives
Agreement Title (French)
Produits cosmétiques avancés utilisant un système d’administration de bioactifs par nanomatériaux
Agreement Type
Contribution
Agreement Value
$154,000.00
Amendment Date
2024-12-02
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Swift Innovations intends to develop an improved delivery system for controlled release of bioactives on epidermal surfaces using customized substrate material.
Description (French)
Swift Innovations a l’intention de développer un système d’administration amélioré pour la libération contrôlée de bioactifs sur les surfaces épidermiques en utilisant un matériau de substrat personnalisé.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Edmonton Strathcona
Federal Riding (French)
Edmonton Strathcona
Federal Riding Number
48019
NAICS Code
446120
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
761130715
Recipient City
Edmonton|Edmonton
Recipient Country
CA
Recipient Legal Name
Swift Innovations Inc.
Recipient Postal Code
T6B 3P3
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2024-2025-Q2-1020201
